Stephen L. Hoffman, Gaithersburg US
Stephen L. Hoffman, Gaithersburg, MD US
Patent application number | Description | Published |
---|---|---|
20100183680 | Purified Plasmodium and Vaccine Compositions - Disclosed are substantially purified | 07-22-2010 |
20120058543 | Purified Plasmodium and Vaccine Compositions - Disclosed are substantially purified | 03-08-2012 |
20120156245 | Methods for the Prevention of Malaria - This application relates to preventing malaria by administering a vaccine. More particularly, this invention relates to a vaccine against malaria infection compromising the administration of attenuated sporozoites to a human or animal. | 06-21-2012 |
20120196289 | NOVEL ASSAY FOR DETECTING IMMUNE RESPONSES INVOLVING ANTIGEN SPECIFIC CYTOKINE AND/OR ANTIGEN SPECIFIC CYTOKINE SECRETING T-CELLS - Here, we describe a sensitive and specific assay and kit for the detection of chemokines having activity that is upregulated by Th-1 cytokines (such IFN-γ) and chemokines that upregulate the activity of Th-1 cytokines (such as IFN-γ). In a typical embodiment, detection of the chemokine monokine induced by gamma interferon (MIG) provides a measure of the biological effect of IFN-γ rather than direct quantitation of IFN-γ or IFN-γ secreting cells per se. Upregulation of MIG expression was observed following in vitro activation of PBMC with defined CD8 | 08-02-2012 |
20120288525 | PHARMACEUTICAL COMPOSITIONS COMPRISING ATTENUATED PLASMODIUM SPOROZOITES AND GLYCOLIPID ADJUVANTS - Disclosed herein are pharmaceutical compositions comprising | 11-15-2012 |
20130224250 | Purified Plasmodium and Vaccine Composition - Disclosed are substantially purified | 08-29-2013 |
20130251750 | Purified Plasmodium and Vaccine Composition - Disclosed are substantially purified | 09-26-2013 |
20140120138 | PHARMACEUTICAL COMPOSITIONS COMPRISING ATTENUATED PLASMODIUM SPOROZOITES AND GLYCOLIPID ADJUVANTS - Disclosed herein are pharmaceutical compositions comprising | 05-01-2014 |